Format

Send to

Choose Destination
Cancer Med. 2016 Jun;5(6):1279-91. doi: 10.1002/cam4.694. Epub 2016 Mar 25.

Development and characterization of an in vitro model of colorectal adenocarcinoma with MDR phenotype.

Author information

1
Departments of Neuroscience, Psychology, Drug Research and Child Health-NEUROFARBA, Section of Pharmacology and Toxicology, University of Florence, Viale G. Pieraccini 6, Florence, Italy.
2
Diagnostic Genetics Unit, Azienda Ospedaliero Universitaria "Careggi", Largo Brambilla 5, Florence, Italy.
3
Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Viale G. Pieraccini 6, Florence, Italy.
4
Department of Experimental and Clinical Medicine, Section of Anatomy and Histology, University of Florence, Largo Brambilla 5, Florence, Italy.

Abstract

The major cause of failure in cancer chemotherapy is the development of multidrug resistance (MDR), and the characterization of biological factors involved in this response to therapy is particularly needed. A doxorubicin-resistant HCT-8/R clone was selected from sensitive parental cells and characterized analyzing several parameters (cell cycle phase distribution, apoptotic activity, expression, distribution and functionality of the P-gp efflux pump, the response to other chemotherapy agents, its ultrastructural features, invasiveness, and transcriptomic profile). HCT-8/R cells showed a peculiar S phase distribution, characterized by a single pulse of proliferation, resistance to drug-mediated apoptosis, increased expression and functionality of P-gp and overexpression of stem cell markers (CD44 and aldehyde dehydrogenase 1A2). At the ultrastructural level, HCT-8/R presented a greater cell volume and several intracytoplasmic vesicles respect to HCT-8. Moreover, the resistant clone was characterized by cross resistance to other cytotoxic drugs and a greater capacity for migration and invasion, compared to parental cells. Our data reinforce the concept that the MDR phenotype in HCT-8/R cells is multifactorial and involves multiple mechanisms, representing an interesting tool to understand the biological basis of MDR and to test strategies that overcome resistance to chemotherapy.

KEYWORDS:

Colorectal cancer; multi drug resistance; trascriptomics

PMID:
27016279
PMCID:
PMC4924386
DOI:
10.1002/cam4.694
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center